US2006269991A1PendingUtilityA1
T cell protein and nucleotides encoding the same
Assignee: BOEHRINGER INGELHEIM PHARMAPriority: Nov 3, 2004Filed: Oct 31, 2005Published: Nov 30, 2006
Est. expiryNov 3, 2024(expired)· nominal 20-yr term from priority
A61P 37/02C07K 14/52C12Q 1/6883C12Q 2600/158A61P 29/00G01N 2500/02
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to mouse and human J12 polynucleotides, polypeptide and anti J12 antibody molecules. The J12 is a cytokine that is preferentially expressed in Th2 cells. The polypeptides and/or antibodies described herein can be used in methods for detection and treatment of certain autoimmune and inflammatory diseases including asthma.
Claims
exact text as granted — not AI-modified1 . An isolated nucleic acid comprising a sequence that encodes a polypeptide with the amino acid sequence of SEQ ID No. 2.
2 . An expression vector comprising the nucleic acid of claim 1 operably linked to an expression control sequence.
3 . A cultured cell comprising the vector of claim 2 .
4 . A method of producing a protein said method comprising culturing a cell of claim 3 under conditions permitting expression of the polypeptide.
5 . An isolated nucleic acid comprising a sequence that encodes a polypeptide with the amino acid sequence of SEQ ID No. 6.
6 . An expression vector comprising the nucleic acid of claim 5 operably linked to an expression control sequence.
7 . A cultured cell comprising the vector of claim 6 .
8 . A method of producing a protein said method comprising culturing a cell of claim 7 under conditions permitting expression of the polypeptide.
9 . An isolated nucleic acid comprising a sequence that encodes a polypeptide with the amino acid sequence of SEQ ID No. 8.
10 . An expression vector comprising the nucleic acid of claim 9 operably linked to an expression control sequence.
11 . A cultured cell comprising the vector of claim 10 .
12 . A method of producing a protein said method comprising culturing a cell of claim 11 under conditions permitting expression of the polypeptide.
13 . An isolated nucleic acid sequence comprising a sequence at least 80% identical to SEQ ID No. 3 or SEQ ID No. 5.
14 . An isolated nucleic acid comprising a sequence comprising a sequence selected from SEQ ID No. 15-18.
15 . An antibody against a polypeptide selected from the list consisting of human J12 var1, human J12 var2 or human J12 var3.
16 . A purified polypeptide, the amino acid sequence of which comprises a sequence at least 90% identical to SEQ ID No. 6 or SEQ ID No. 8.
17 . A method of identifying a compound that inhibits the binding of J12 to its natural binding partner, the method comprising,
a) providing a J12 polypeptide comprising selected from SEQ ID No. 2, 6-8; b) contacting the polypeptide with its natural binding partner and a test compound c) determining whether binding of the binding partner to the polypeptide is decreases in the presence of the test compound, a decrease in said binding being an indication that the test compound inhibits the binding of J12 to its binding partner.Join the waitlist — get patent alerts
Track US2006269991A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.